- This event has passed.
Science 1st: From Early Prevention to Improved Treatment
August 1 @ 3:30 pm - 7:30 pm EDT$10
Science 1st: From Early Prevention to Improved Treatment – Changing the Trajectory of Lung Cancer
August 1 | 3:30 – 7:30 PM ET
In this program, experts and startups in this space will discuss new biomarkers for lung cancer, as well as new treatments for the disease like immunotherapy and precision radiology that lead to better patient experiences.
Global Head, Lung Cancer Initiative
Johnson & Johnson Innovation
General Public $20 | Student/Academic $10
Lung cancer is the leading cause of cancer death worldwide . Exposure to hazards certainly can play a causative role in lung cancer, but many who are exposed to these hazards don’t go on to develop lung cancer and similarly, people who are not exposed to hazards can develop lung cancer.
From a detection and treatment perspective, lung cancer is difficult to detect at an early stage, and the low survival rates in this patient population reflects this late stage detection. Advancements have been made in the biology that drives lung cancer, as well as tools for early detection. These advances, coupled with genomic profiling, and novel biomarkers, have led to the development of new treatments and radiation therapies has the potential to reduce the mortality associated with lung cancer. 
In this program, experts and startups in this space will discuss new biomarkers for lung cancer, and new treatments for the disease that they feel lead to better patient experiences. We will also cover early detection and prevention initiatives and technologics for lung cancer that can be used on patients at high risk of developing the disease, and for correct diagnosis.
Source: American Lung Cancer Research Foundation  American Lung Association  US National Library of Medicine, National Institutes of Health
Partner – OICR or Lung Cancer Canada